Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02XFR
|
|||
| Former ID |
DNC006726
|
|||
| Drug Name |
3-chloro-N-(4-methylthiazol-2-yl)benzamide
|
|||
| Synonyms |
3-chloro-N-(4-methyl-1,3-thiazol-2-yl)benzamide; CHEMBL212529; 3-chloro-N-(4-methylthiazol-2-yl)benzamide; AC1LI75J; MolPort-003-812-188; ZINC477397; BDBM50186320; AKOS003848769; MCULE-7000942763
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H9ClN2OS
|
|||
| Canonical SMILES |
CC1=CSC(=N1)NC(=O)C2=CC(=CC=C2)Cl
|
|||
| InChI |
1S/C11H9ClN2OS/c1-7-6-16-11(13-7)14-10(15)8-3-2-4-9(12)5-8/h2-6H,1H3,(H,13,14,15)
|
|||
| InChIKey |
MXGUAAMFCPDOEZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3371-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.